UAS regulatory sequences drive expression of an inverted repeat.
Expression of tapJF02107 in the fat body under the control of Scer\GAL4DcG results in significant hyperglycaemia.
Expression of tapJF02107 in the fat body under the control of Scer\GAL4DcG results in significant lower trehalose levels than controls.
Scer\GAL4phtm.PO, tapJF02107 has increased mortality during development phenotype, suppressible by Cpr49AhUAS.cDNA/pdm3UAS.ORF.GW.Tag:HA, Scer\GAL4phtm.PO
Scer\GAL4phtm.PO, tapJF02107 has decreased size | larval stage phenotype, suppressible by Cpr49AhUAS.cDNA/pdm3UAS.ORF.GW.Tag:HA, Scer\GAL4phtm.PO
Scer\GAL4phtm.PO, tapJF02107 has decreased size | larval stage phenotype, non-suppressible by Cpr49AhUAS.cDNA, Scer\GAL4phtm.PO
Scer\GAL4phtm.PO, tapJF02107 has decreased size | larval stage phenotype, non-suppressible by pdm3UAS.ORF.GW.Tag:HA/Scer\GAL4phtm.PO
Scer\GAL4phtm.PO, tapJF02107 has partially lethal - majority die phenotype, non-suppressible by Cpr49AhUAS.cDNA, Scer\GAL4phtm.PO
Scer\GAL4phtm.PO, tapJF02107 has partially lethal - majority die phenotype, non-suppressible by pdm3UAS.ORF.GW.Tag:HA/Scer\GAL4phtm.PO
Scer\GAL4phtm.PO, tapJF02107 has prothoracic gland | larval stage phenotype, suppressible by Cpr49AhUAS.cDNA/pdm3UAS.ORF.GW.Tag:HA, Scer\GAL4phtm.PO
Scer\GAL4phtm.PO, tapJF02107 has prothoracic gland | larval stage phenotype, non-suppressible by Cpr49AhUAS.cDNA, Scer\GAL4phtm.PO
Scer\GAL4phtm.PO, tapJF02107 has prothoracic gland | larval stage phenotype, non-suppressible by pdm3UAS.ORF.GW.Tag:HA/Scer\GAL4phtm.PO